What is Jude?
Jude operates within the critical domain of bladder health, providing innovative solutions aimed at improving patient outcomes and quality of life. Headquartered in London, United Kingdom, the company is positioned to address a significant unmet need in the healthcare market. Its focus on bladder health solutions suggests a specialized approach within the broader health-tech industry, potentially leveraging advancements in medical devices, diagnostics, or therapeutic interventions.
How much funding has Jude raised?
Jude has raised a total of $6.8M across 2 funding rounds:
Other Financing Round
$2.6M
Angel/Seed
$4.2M
Other Financing Round (2022): $2.6M with participation from Access VC, David Rowan, and Samos VC
Angel/Seed (2023): $4.2M led by Eka Ventures and Joyance Partners
Key Investors in Jude
Eka Ventures
Eka VC is a venture capital firm that invests in founders creating positive system change through technology. They focus on building category-defining companies that contribute to a more sustainable, healthy, and inclusive economy.
Joyance Partners
Joyance invests in companies that leverage science and technology to enhance quality of life across North America, Europe, and Asia. The firm focuses on the health and consumer sectors, targeting investments from pre-seed to Series A stages.
What's next for Jude?
The recent major strategic investment indicates that Jude is likely entering a phase of accelerated scaling and market penetration. This influx of capital, coupled with the strategic alignment from investors such as Eka Ventures and Joyance Partners, suggests a focus on expanding product development, enhancing clinical validation, and broadening market reach. The company's trajectory points towards solidifying its position as a key player in the bladder health sector, with potential for further innovation and strategic partnerships.
See full Jude company page
